RVNC
Revance Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.65
+0.00 (+0.00%)
Company Profile
CEO
Mark J. Foley
IPO Date
2014-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.65
Prev. Close
$3.65
Day Low
$3.65
Day High
$3.65
52W Low
$2.30
52W High
$7.56
Market Cap
$0.38B